Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents
Andrographolide (AGP), a naturally occurring bioactive compound, has been investigated as a lead compound in cancer drug development. Its multidimensional therapeutic effects have raised interest among medicinal chemists, which has led to extensive structural modification of the compound, resulting...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/80553/ http://psasir.upm.edu.my/id/eprint/80553/1/ANDRO.pdf |
| _version_ | 1848858916759273472 |
|---|---|
| author | Soo, Hon Liong Quah, Shun Ying Sulaiman, Ibrahim Sagineedu, Sreenivasa Rao Lim, Chee Woei Stanslas, Johnson |
| author_facet | Soo, Hon Liong Quah, Shun Ying Sulaiman, Ibrahim Sagineedu, Sreenivasa Rao Lim, Chee Woei Stanslas, Johnson |
| author_sort | Soo, Hon Liong |
| building | UPM Institutional Repository |
| collection | Online Access |
| description | Andrographolide (AGP), a naturally occurring bioactive compound, has been investigated as a lead compound in cancer drug development. Its multidimensional therapeutic effects have raised interest among medicinal chemists, which has led to extensive structural modification of the compound, resulting in analogues with improved pharmacological and pharmaceutical properties. Nevertheless, the analogues with the improved properties need to be rigorously studied to identify drug-like lead compounds. We scrutinised articles published from 2012 to 2018, to objectively provide opinions on the mechanisms of action of AGP and its analogues, as well as their potential as viable anticancer drugs. Preclinical and clinical data, along with the extensive medicinal chemistry efforts, indicate the compounds are potential anticancer agents with specific value in treating recalcitrant cancers such as pancreatic and lung cancers. |
| first_indexed | 2025-11-15T12:21:03Z |
| format | Article |
| id | upm-80553 |
| institution | Universiti Putra Malaysia |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-15T12:21:03Z |
| publishDate | 2019 |
| publisher | Elsevier |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | upm-805532021-04-27T03:14:14Z http://psasir.upm.edu.my/id/eprint/80553/ Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents Soo, Hon Liong Quah, Shun Ying Sulaiman, Ibrahim Sagineedu, Sreenivasa Rao Lim, Chee Woei Stanslas, Johnson Andrographolide (AGP), a naturally occurring bioactive compound, has been investigated as a lead compound in cancer drug development. Its multidimensional therapeutic effects have raised interest among medicinal chemists, which has led to extensive structural modification of the compound, resulting in analogues with improved pharmacological and pharmaceutical properties. Nevertheless, the analogues with the improved properties need to be rigorously studied to identify drug-like lead compounds. We scrutinised articles published from 2012 to 2018, to objectively provide opinions on the mechanisms of action of AGP and its analogues, as well as their potential as viable anticancer drugs. Preclinical and clinical data, along with the extensive medicinal chemistry efforts, indicate the compounds are potential anticancer agents with specific value in treating recalcitrant cancers such as pancreatic and lung cancers. Elsevier 2019-09 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/80553/1/ANDRO.pdf Soo, Hon Liong and Quah, Shun Ying and Sulaiman, Ibrahim and Sagineedu, Sreenivasa Rao and Lim, Chee Woei and Stanslas, Johnson (2019) Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents. Drug Discovery Today, 24 (9). pp. 1890-1898. ISSN 1359-6446; ESSN: 1878-5832 https://www.sciencedirect.com/science/article/pii/S1359644618302216 10.1016/j.drudis.2019.05.017 |
| spellingShingle | Soo, Hon Liong Quah, Shun Ying Sulaiman, Ibrahim Sagineedu, Sreenivasa Rao Lim, Chee Woei Stanslas, Johnson Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents |
| title | Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents |
| title_full | Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents |
| title_fullStr | Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents |
| title_full_unstemmed | Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents |
| title_short | Advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents |
| title_sort | advances and challenges in developing andrographolide and its analogues as cancer therapeutic agents |
| url | http://psasir.upm.edu.my/id/eprint/80553/ http://psasir.upm.edu.my/id/eprint/80553/ http://psasir.upm.edu.my/id/eprint/80553/ http://psasir.upm.edu.my/id/eprint/80553/1/ANDRO.pdf |